LFCR · Company research
Lifecore Biomedical, Inc. (LFCR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| At three Boston conferences, Lifecore leaders will meet prospective customers. - Stock Titan | At three Boston conferences, Lifecore leaders will meet prospective customers. Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their Shareholders | Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether MISTRAS Group's $20.35/share sale to H.I.G. Capital, Lifecore Biomedical's $6.28/share sale to Webster Equity Partners, and Marygold Companies' $2.00/share sale to Madison Dearborn Partners represent fair deals for shareholders. The firm may seek increased consideration, additional disclosures, and other relief on behalf of shareholders. | View source ↗ | GlobeNewswire Inc. | Oct 4, 2026 | bearish | -1 | 1 |
| Lifecore Biomedical (NasdaqGS:LFCR) Stock Forecast & Analyst Predictions - Simply Wall Street | Lifecore Biomedical (NasdaqGS:LFCR) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 1, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical: Bid Is Underwhelming (NASDAQ:LFCR) - Seeking Alpha | Lifecore Biomedical: Bid Is Underwhelming (NASDAQ:LFCR) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 29, 2026 | neutral | 0 | 0.6 |
| Votes against certain rival proposals are part of Wynnefield's merger pledge at Lifecore Biomedical (LFCR). - Stock Titan | Votes against certain rival proposals are part of Wynnefield's merger pledge at Lifecore Biomedical (LFCR). Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News - Investorideas.com | Lifecore Biomedical (Nasdaq: LFCR) Closes up on Acquisition News Investorideas.com | View source ↗ | Investorideas.com | Sep 29, 2026 | neutral | 0 | 0.6 |
| A 49.5% premium is built into Lifecore Biomedical’s (LFCR) proposed sale. The cash price is only part of the deal. - Stock Titan | A 49.5% premium is built into Lifecore Biomedical’s (LFCR) proposed sale. The cash price is only part of the deal. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire | LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders Business Wire | View source ↗ | Business Wire | Sep 28, 2026 | neutral | 0 | 0.6 |
| Top stock movements in today's session. - ChartMill | Top stock movements in today's session. ChartMill | View source ↗ | ChartMill | Sep 28, 2026 | neutral | 0 | 0.6 |
| A $6.28-a-share merger gets a voting pledge from Legion Partners at Lifecore Biomedical (LFCR). - Stock Titan | A $6.28-a-share merger gets a voting pledge from Legion Partners at Lifecore Biomedical (LFCR). Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business (NASDAQ:LFCR) - Seeking Alpha | Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business (NASDAQ:LFCR) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 14, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge Lower - Ratio Spread Trade - dars.gov.et | Lifecore Biomedical (LFCR) Holds Above $4.50 Support as Shares Edge Lower - Ratio Spread Trade dars.gov.et | View source ↗ | dars.gov.et | Aug 13, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market - Yahoo Finance | Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market Yahoo Finance | View source ↗ | Yahoo Finance | Jul 15, 2026 | neutral | 0 | 0.6 |
| LFCR Forecast — Price Target — Prediction for 2027 - TradingView | LFCR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook - Yahoo Finance | Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook Yahoo Finance | View source ↗ | Yahoo Finance | Jun 13, 2026 | neutral | 0 | 0.6 |
| How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations - Yahoo Finance | How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations Yahoo Finance | View source ↗ | Yahoo Finance | May 28, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.